OpenURL Connection Search

Select item for more details and to access through your institution.

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 9243, doi. 10.1007/s00432-023-04839-3
By:
- Kraskowski, Oliver;
- Stratmann, Jan A.;
- Wiesweg, Marcel;
- Eberhardt, Wilfried;
- Metzenmacher, Martin;
- Schmid, Kurt W.;
- Herold, Thomas;
- Schildhaus, Hans-Ulrich;
- Darwiche, Kaid;
- Aigner, Clemens;
- Stuschke, Martin;
- Laue, Katharina;
- Zaun, Gregor;
- Kasper, Stefan;
- Hense, Jörg;
- Sebastian, Martin;
- Schuler, Martin;
- Pogorzelski, Michael
Publication type:
Article
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4315, doi. 10.1007/s00432-022-04314-5
By:
- Rosery, Vivian;
- Mika, Stephan;
- Schmid, Kurt Werner;
- Reis, Henning;
- Stuschke, Martin;
- Treckmann, Jürgen;
- Markus, Peter;
- Schumacher, Brigitte;
- Albers, David;
- Mende, Bastian;
- Lahner, Harald;
- Wiesweg, Marcel;
- Schuler, Martin;
- Siveke, Jens T.;
- Kasper, Stefan
Publication type:
Article
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.
Published in:
Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 6, p. 1559, doi. 10.1007/s00432-020-03184-z
By:
- Welt, Anja;
- Bogner, Simon;
- Arendt, Marina;
- Kossow, Josef;
- Huffziger, Antonia;
- Pohlkamp, Christian;
- Steiniger, Heike;
- Becker, Ute;
- Alashkar, Ferras;
- Kohl, Marzena;
- Wiesweg, Marcel;
- Richly, Heike;
- Hense, Jörg;
- Scheulen, Max E.;
- Schuler, Martin;
- Seeber, Siegfried;
- Tewes, Mitra
Publication type:
Article
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21637-y
By:
- Guberina, Maja;
- Herrmann, Ken;
- Pöttgen, Christoph;
- Guberina, Nika;
- Hautzel, Hubertus;
- Gauler, Thomas;
- Ploenes, Till;
- Umutlu, Lale;
- Wetter, Axel;
- Theegarten, Dirk;
- Aigner, Clemens;
- Eberhardt, Wilfried E. E.;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Karpf-Wissel, Rüdiger;
- Santiago Garcia, Alina;
- Darwiche, Kaid;
- Stuschke, Martin
Publication type:
Article
Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.
Published in:
Clinical Lung Cancer, 2021, v. 22, n. 5, p. e668, doi. 10.1016/j.cllc.2020.11.008
By:
- Metzenmacher, Martin;
- Goetz, Moritz;
- Herold, Thomas;
- Stuschke, Martin;
- Aigner, Clemens;
- Darwiche, Kaid;
- Eberhardt, Wilfried E.;
- Schuler, Martin;
- Wiesweg, Marcel
Publication type:
Article
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.
Published in:
2018
By:
- Oezkan, Filiz;
- Herold, Thomas;
- Darwiche, Kaid;
- Eberhardt, Wilfried E E;
- Worm, Karl;
- Christoph, Daniel C;
- Wiesweg, Marcel;
- Freitag, Lutz;
- Schmid, Kurt-Werner;
- Theegarten, Dirk;
- Hager, Thomas;
- Koenig, Michael J;
- He, Kai;
- Taube, Christian;
- Schuler, Martin;
- Breitenbuecher, Frank
Publication type:
journal article
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).
Published in:
Oncology Research & Treatment, 2023, v. 46, n. 3, p. 89, doi. 10.1159/000529012
By:
- Virchow, Isabel;
- Treckmann, Jürgen-Walter;
- Prasnikar, Nicole;
- Linden, Gabriele;
- Markus, Peter;
- Schumacher, Brigitte;
- Albers, David;
- Herold, Thomas;
- Ting, Saskia;
- Schmidt, Hartmut;
- Radunz, Sonja;
- Wiesweg, Marcel;
- Siveke, Jens;
- Schuler, Martin;
- Kasper, Stefan
Publication type:
Article
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64302-2
By:
- Richlitzki, Cedric;
- Wiesweg, Marcel;
- Metzenmacher, Martin;
- Guberina, Nika;
- Pöttgen, Christoph;
- Hautzel, Hubertus;
- Eberhardt, Wilfried E. E.;
- Darwiche, Kaid;
- Theegarten, Dirk;
- Aigner, Clemens;
- Bölükbas, Servet;
- Schuler, Martin;
- Stuschke, Martin;
- Guberina, Maja
Publication type:
Article
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease.
Published in:
Cancers, 2024, v. 16, n. 6, p. 1174, doi. 10.3390/cancers16061174
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Guberina, Nika;
- Hoffmann, Christian;
- Wiesweg, Marcel;
- Richlitzki, Cedric;
- Metzenmacher, Martin;
- Aigner, Clemens;
- Bölükbas, Servet;
- Gauler, Thomas;
- Eberhardt, Wilfried E. E.;
- Forsting, Michael;
- Herrmann, Ken;
- Theegarten, Dirk;
- Darwiche, Kaid;
- Jendrossek, Verena;
- Stuschke, Martin;
- Schuler, Martin
Publication type:
Article
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients.
Published in:
Cancers, 2023, v. 15, n. 11, p. 3029, doi. 10.3390/cancers15113029
By:
- Warnecke, Eva;
- Salvador Comino, Maria Rosa;
- Kocol, Dilara;
- Hosters, Bernadette;
- Wiesweg, Marcel;
- Bauer, Sebastian;
- Welt, Anja;
- Heinzelmann, Anna;
- Müller, Sandy;
- Schuler, Martin;
- Teufel, Martin;
- Tewes, Mitra
Publication type:
Article
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Published in:
Cancers, 2020, v. 12, n. 2, p. 353, doi. 10.3390/cancers12020353
By:
- Metzenmacher, Martin;
- Váraljai, Renáta;
- Hegedüs, Balazs;
- Cima, Igor;
- Forster, Jan;
- Schramm, Alexander;
- Scheffler, Björn;
- Horn, Peter A.;
- Klein, Christoph A.;
- Szarvas, Tibor;
- Reis, Hennig;
- Bielefeld, Nicola;
- Roesch, Alexander;
- Aigner, Clemens;
- Kunzmann, Volker;
- Wiesweg, Marcel;
- Siveke, Jens T.;
- Schuler, Martin;
- Lueong, Smiths S.
Publication type:
Article
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.
Published in:
Breast Cancer Research & Treatment, 2013, v. 142, n. 1, p. 81, doi. 10.1007/s10549-013-2718-4
By:
- Welt, Anja;
- Tewes, Mitra;
- Aktas, Bahriye;
- Hoffmann, Oliver;
- Wiesweg, Marcel;
- Ting, Saskia;
- Reis, Henning;
- Worm, Karl;
- Richly, Heike;
- Hense, Jörg;
- Palmer, Michael;
- Lee, Benjamin;
- Wendling, Johanna;
- Kossow, Josef;
- Scheulen, Max;
- Lehnerdt, Cathrin;
- Kohl, Marzena;
- Derks, Cordula;
- Skottky, Silke;
- Haus, Ulrike
Publication type:
Article
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Published in:
Cancer Medicine, 2020, v. 9, n. 13, p. 4527, doi. 10.1002/cam4.3092
By:
- Welt, Anja;
- Wiesweg, Marcel;
- Theurer, Sarah;
- Abenhardt, Wolfgang;
- Groschek, Matthias;
- Müller, Lothar;
- Schröder, Jan;
- Tewes, Mitra;
- Chiabudini, Marco;
- Potthoff, Karin;
- Bankfalvi, Agnes;
- Marschner, Norbert;
- Schuler, Martin;
- Breitenbücher, Frank
Publication type:
Article
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition.
Published in:
2021
By:
- Guberina, Maja;
- Darwiche, Kaid;
- Hautzel, Hubertus;
- Pöttgen, Christoph;
- Guberina, Nika;
- Gauler, Thomas;
- Ploenes, Till;
- Umutlu, Lale;
- Theegarten, Dirk;
- Aigner, Clemens;
- Eberhardt, Wilfried E. E.;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Karpf-Wissel, Rüdiger;
- Schuler, Martin;
- Herrmann, Ken;
- Stuschke, Martin
Publication type:
journal article
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy.
Published in:
BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-021-09111-w
By:
- Wessolly, Michael;
- Stephan-Falkenau, Susann;
- Streubel, Anna;
- Wiesweg, Marcel;
- Borchert, Sabrina;
- Mairinger, Elena;
- Kollmeier, Jens;
- Reis, Henning;
- Bauer, Torsten;
- Schmid, Kurt Werner;
- Mairinger, Thomas;
- Schuler, Martin;
- Mairinger, Fabian D.
Publication type:
Article
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Published in:
2020
By:
- Kasper, Stefan;
- Meiler, Johannes;
- Knipp, Heike;
- Höhler, Thomas;
- Reimer, Peter;
- Steinmetz, Tilman;
- Berger, Winfried;
- Linden, Gabriele;
- Reis, Henning;
- Markus, Peter;
- Paul, Andreas;
- Dechêne, Alexander;
- Schumacher, Brigitte;
- Kostbade, Karina;
- Virchow, Isabel;
- Ting, Saskia;
- Worm, Karl;
- Schmid, Kurt W.;
- Herold, Thomas;
- Wiesweg, Marcel
Publication type:
journal article
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer.
Published in:
2018
By:
- Wiesweg, Marcel;
- Reis, Henning;
- Köster, Tobias;
- Goetz, Moritz;
- Worm, Karl;
- Herold, Thomas;
- Paul, Andreas;
- Dechêne, Alexander;
- Schumacher, Brigitte;
- Markus, Peter;
- Virchow, Isabel;
- Kostbade, Karina;
- Wolf, Nathalie;
- Zaun, Gregor;
- Metzenmacher, Martin;
- Schmid, Kurt W.;
- Schuler, Martin;
- Kasper, Stefan
Publication type:
journal article
Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.124.267473
By:
- Kessler, Lukas;
- Schwaning, Felix;
- Metzenmacher, Martin;
- Pabst, Kim;
- Siveke, Jens;
- Trajkovic-Arsic, Marija;
- Schaarschmidt, Benedikt;
- Wiesweg, Marcel;
- Aigner, Clemens;
- Plönes, Till;
- Darwiche, Kaid;
- Bölükbas, Servet;
- Stuschke, Martin;
- Umutlu, Lale;
- Nader, Michael;
- Theegarten, Dirk;
- Hamacher, Rainer;
- Eberhardt, Wilfried E. E.;
- Schuler, Martin;
- Herrmann, Ken
Publication type:
Article
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266979
By:
- Schuler, Martin;
- Hense, Jörg;
- Darwiche, Kaid;
- Michels, Sebastian;
- Hautze, Hubertus;
- Kobe, Carsten;
- Lueong, Smiths;
- Metzenmacher, Martin;
- Herold, Thomas;
- Zaun, Gregor;
- Laue, Katharina;
- Drzezga, Alexander;
- Theegarten, Dirk;
- Nensa, Felix;
- Wolf, Jürgen;
- Herrmann, Ken;
- Wiesweg, Marcel
Publication type:
Article
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 851, doi. 10.2967/jnumed.123.266979
By:
- Schuler, Martin;
- Hense, Jörg;
- Darwiche, Kaid;
- Michels, Sebastian;
- Hautzel, Hubertus;
- Kobe, Carsten;
- Lueong, Smiths;
- Metzenmacher, Martin;
- Herold, Thomas;
- Zaun, Gregor;
- Laue, Katharina;
- Drzezga, Alexander;
- Theegarten, Dirk;
- Nensa, Felix;
- Wolf, Jürgen;
- Herrmann, Ken;
- Wiesweg, Marcel
Publication type:
Article
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1540, doi. 10.2967/jnumed.123.265664
By:
- Kersting, David;
- Sandach, Patrick;
- Sraieb, Miriam;
- Wiesweg, Marcel;
- Metzenmacher, Martin;
- Darwiche, Kaid;
- Oezkan, Filiz;
- Bölukbas, Servet;
- Stuschke, Martin;
- Umutlu, Lale;
- Nader, Michael;
- Hamacher, Rainer;
- Fendler, Wolfgang P.;
- Wienker, Johannes;
- Eberhardt, Wilfried E. E.;
- Schuler, Martin;
- Herrmann, Ken;
- Hautzel, Hubertus
Publication type:
Article
SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1191, doi. 10.2967/jnumed.122.265161
By:
- Zaun, Gregor;
- Weber, Manuel;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Hilser, Thomas;
- Zaun, Yasmin;
- Liffers, Sven;
- Pogorzelski, Michael;
- Virchow, Isabel;
- Eberhardt, Wilfried;
- Theurer, Sarah;
- Sabbah, Tanja Abu;
- Reissig, Timm M.;
- Stuschke, Martin;
- Kürten, Cornelius;
- Hussain, Timon;
- Lang, Stephan;
- Kasper, Stefan;
- Fendler, Wolfgang P.;
- Herrmann, Ken
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schule, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 31, doi. 10.2967/jnumed.120.260646
By:
- Guberina, Maja;
- Pöttgen, Christoph;
- Metzenmacher, Martin;
- Wiesweg, Marcel;
- Schuler, Martin;
- Aigner, Clemens;
- Ploenes, Till;
- Umutlu, Lale;
- Gauler, Thomas;
- Darwiche, Kaid;
- Stamatis, Georgios;
- Theegarten, Dirk;
- Hautzel, Hubertus;
- Jentzen, Walter;
- Guberina, Nika;
- Herrmann, Ken;
- Eberhardt, Wilfried E. E.;
- Stuschke, Martin
Publication type:
Article
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Published in:
International Journal of Cancer, 2018, v. 143, n. 7, p. 1764, doi. 10.1002/ijc.31547
By:
- Reis, Henning;
- van der Vos, Kristan E.;
- Niedworok, Christian;
- Herold, Thomas;
- Módos, Orsolya;
- Szendrői, Attila;
- Hager, Thomas;
- Ingenwerth, Marc;
- Vis, Daniël J.;
- Behrendt, Mark A.;
- de Jong, Jeroen;
- van der Heijden, Michiel S.;
- Peyronnet, Benoit;
- Mathieu, Romain;
- Wiesweg, Marcel;
- Ablat, Jason;
- Okon, Krzysztof;
- Tolkach, Yuri;
- Keresztes, David;
- Nagy, Nikolett
Publication type:
Article
Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms.
Published in:
Der Internist, 2022, v. 63, n. 7, p. 717, doi. 10.1007/s00108-022-01366-0
By:
- Wiesweg, Marcel;
- Eberhardt, Wilfried E.;
- Schuler, Martin;
- Plönes, Till
Publication type:
Article
Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.
Published in:
Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 1, p. 545, doi. 10.1002/jcsm.13158
By:
- Keyl, Julius;
- Hosch, René;
- Berger, Aaron;
- Ester, Oliver;
- Greiner, Tobias;
- Bogner, Simon;
- Treckmann, Jürgen;
- Ting, Saskia;
- Schumacher, Brigitte;
- Albers, David;
- Markus, Peter;
- Wiesweg, Marcel;
- Forsting, Michael;
- Nensa, Felix;
- Schuler, Martin;
- Kasper, Stefan;
- Kleesiek, Jens
Publication type:
Article
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival.
Published in:
Theranostics, 2024, v. 14, n. 14, p. 5400, doi. 10.7150/thno.98819
By:
- Mavroeidi, Ilektra Antonia;
- Romanowicz, Anna;
- Haake, Tristan;
- Wienker, Johannes;
- Metzenmacher, Martin;
- Darwiche, Kaid;
- Oezkan, Filiz;
- Bölükbas, Servet;
- Stuschke, Martin;
- Umutlu, Lale;
- Opitz, Marcel;
- Nader, Michael;
- Hamacher, Rainer;
- Siveke, Jens;
- Winantea, Jane;
- Fendler, Wolfgang P.;
- Wiesweg, Marcel;
- Eberhardt, Wilfried E. E.;
- Herrmann, Ken;
- Theegarten, Dirk
Publication type:
Article

Found: 32

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.

Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT.

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.

Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.

A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease.

Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients.

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.

Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.

Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition.

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy.

Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.

Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer.

Fibroblast Activation Protein-Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.

Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.

Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.

<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.

SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms.

Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survival.